CD86 and Huntington disease: Thus, we investigated the capacity of DC subsets from OvC patients and HD to respond to Poly(I:C) by measuring the change in expression of CD40, CD80, CD86, PDL1, CD276, and ILT3 (Supplementary Figure 4).